Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$40.07

2.67 (7.14%)

17:16
05/21/19
05/21
17:16
05/21/19
17:16

Point72 Asset Management takes 5.0% passive stake in PTC Therapeutics

Point72 Asset Management disclosed a 5.0% stake in PTC Therapeutics, which represents over 2.93M shares. The filing does not allow for activism.

  • 21

    May

  • 31

    May

  • 12

    Jun

PTCT PTC Therapeutics
$40.07

2.67 (7.14%)

05/09/19
LEHM
05/09/19
NO CHANGE
Target $245
LEHM
Equal Weight
Barclays cuts Biogen target to $245 on reduced Spinraza estimates
Barclays analyst Geoff Meacham lowered his price target for Biogen (BIIB) to $245 from $250 citing growing uncertainty in spinal muscular atrophy. Concerns over Spinraza in spinal muscular atrophy have intensified with the impending launch of Novartis' (NVS) gene therapy Zolgensma and Roche (RHHBY)/PTC's (PTCT) oral risdiplam, Meacham tells investors in a research note. The analyst says his feedback from key opinion leaders was "direct and unequivocal," with the leaders predicting "robust uptake" of both Zolgensma and risdiplam given signs of improved efficacy. This was at the expense of Spinraza driven by the clinical burden of intrathecal injections, says Meacham. On the basis of this feedback, he lowered his longer-term Spinraza outlook by ~$150M per year. The analyst now forecasts sales of $2.0B in 2019, declining to $1.7B in 2023. He keeps an Equal Weight rating on Biogen.
05/13/19
BOFA
05/13/19
UPGRADE
BOFA
Buy
PTC Therapeutics upgraded to Buy from Neutral at BofA/Merrill
05/13/19
BOFA
05/13/19
UPGRADE
Target $49
BOFA
Buy
PTC Therapeutics upgraded to Buy following data update at BofA/Merrill
As previous reported, BofA/Merrill analyst Tazeen Ahmad upgraded PTC Therapeutics to Buy from Neutral and raised its price target to $49 from $43 following the data update at the American Academy of Neurology conference for risdiplam in the treatment of spinal muscular atrophy. Ahmad now has a higher conviction risdiplam will reach the market and be successfully marketed by partner Roche. His un-risk adjusted peak sales estimate is $4.8B, much higher than PTC's $2B estimate, equating to $700M in royalty payments in peak sales years. Tazeen also updated his model to include $75M i pipeline value for the company's early stage gene splicing program and expects investor interest to start to shift to PTC's fully owned pipeline in the near future.
05/20/19
RBCM
05/20/19
NO CHANGE
RBCM
RBC says posting hints at Zolgensma label potentially positive for PTC, Biogen
RBC Capital analyst Brian Abrahams noted a new posting on ClinicalTrials.gov that he said "looks like" an expanded access program for Zolgensma that he believes could possibly offer some hints as to the potential label under discussion with the FDA. The most interesting parts are the inclusion criteria, which he thinks could "represent a middle ground" in terms of the breadth of label Novartis (NVS) could obtain for the drug. If the posting is predictive of Zolgensma's initial label, he said he would see it as an incremental positive for Biogen (BIIB), as it would potentially reduce the worst-case scenario of Zolgensma being approved with no age or weight restrictions. It would also be an incremental positive for PTC Therapeutics (PTCT), which Abrahams noted is looking to enter the space.

TODAY'S FREE FLY STORIES

AGN

Allergan

$165.75

36.1 (27.84%)

09:52
06/25/19
06/25
09:52
06/25/19
09:52
Options
Call flow in Allergan last week suggests potential deal leakage »

Call flow in Allergan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHG

InterContinental

$67.24

-0.1 (-0.15%)

, SCHYY

Sands China

$0.00

(0.00%)

09:49
06/25/19
06/25
09:49
06/25/19
09:49
Hot Stocks
InterContinental, Sands China extend partnership »

InterContinental (IHG)…

IHG

InterContinental

$67.24

-0.1 (-0.15%)

SCHYY

Sands China

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AMZN

Amazon.com

$1,914.14

0.71 (0.04%)

, ROKU

Roku

$98.12

-1.86 (-1.86%)

09:49
06/25/19
06/25
09:49
06/25/19
09:49
Periodicals
Amazon introducing three new smart televisions, Ars Technica reports »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,914.14

0.71 (0.04%)

ROKU

Roku

$98.12

-1.86 (-1.86%)

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

GTES

Gates Industrial

$12.72

1.905 (17.61%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47
Hot Stocks
Gates Industrial rises 19.1% »

Gates Industrial is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYX

Pyxus

$16.91

3.49 (26.01%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47
Hot Stocks
Pyxus rises 26.5% »

Pyxus is up 26.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$167.63

37.98 (29.29%)

09:47
06/25/19
06/25
09:47
06/25/19
09:47
Hot Stocks
Allergan rises 29.4% »

Allergan is up 29.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
06/25/19
06/25
09:45
06/25/19
09:45
General news
New Home Sales to be reported at 10:00 »

May New Home Sales will…

09:45
06/25/19
06/25
09:45
06/25/19
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

June Richmond Fed…

09:45
06/25/19
06/25
09:45
06/25/19
09:45
General news
Consumer Confidence to be reported at 10:00 »

June Consumer Confidence…

HPE

HP Enterprise

$15.00

(0.00%)

09:41
06/25/19
06/25
09:41
06/25/19
09:41
Conference/Events
HP Enterprise management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

HRL

Hormel Foods

$42.15

(0.00%)

, AGN

Allergan

$129.65

(0.00%)

09:40
06/25/19
06/25
09:40
06/25/19
09:40
Options
Unusually active option classes on open June 25th »

Unusual total active…

HRL

Hormel Foods

$42.15

(0.00%)

AGN

Allergan

$129.65

(0.00%)

BHC

Bausch Health

$23.76

(0.00%)

GRUB

GrubHub

$72.05

(0.00%)

PM

Philip Morris

$77.83

(0.00%)

NOV

National Oilwell

$21.28

(0.00%)

RIOT

Riot Blockchain

$3.05

(0.00%)

FDX

FedEx

$160.88

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$12.73

(0.00%)

ATVI

Activision Blizzard

$47.16

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 30

    Jul

  • 30

    Jul

  • 31

    Jul

  • 27

    Aug

  • 13

    Nov

09:40
06/25/19
06/25
09:40
06/25/19
09:40
General news
U.S. new home sales preview: »

U.S. new home sales…

09:40
06/25/19
06/25
09:40
06/25/19
09:40
General news
U.S. consumer confidence preview: »

U.S. consumer confidence…

CZR

Caesars

$11.43

1.44 (14.41%)

, ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

09:34
06/25/19
06/25
09:34
06/25/19
09:34
Conference/Events
Wolfe Research gaming analyst to hold an analyst/industry webcast »

Leisure, Lodging &…

CZR

Caesars

$11.43

1.44 (14.41%)

ERI

Eldorado Resorts

$45.86

-5.36 (-10.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 02

    Jul

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

, AGN

Allergan

$129.65

-1.32 (-1.01%)

09:31
06/25/19
06/25
09:31
06/25/19
09:31
Hot Stocks
AbbVie says looked at Allergan deal for over a year »

Says: Highly unlikely to…

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

AGN

Allergan

$129.65

-1.32 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

MHK

Mohawk

$146.01

0.025 (0.02%)

09:31
06/25/19
06/25
09:31
06/25/19
09:31
Recommendations
Mohawk analyst commentary  »

Mohawk challenges persist…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
06/25/19
06/25
09:30
06/25/19
09:30
General news
Treasury Action: Treasuries are holding modest gains »

Treasury Action:…

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
HSBC to hold a conference »

Transport, Infrastructure…

09:25
06/25/19
06/25
09:25
06/25/19
09:25
General news
U.S. April FHFA home price index was up 0.4% to 274.7 »

U.S. April FHFA home…

BJRI

BJ's Restaurants

$43.61

0.81 (1.89%)

, CAKE

Cheesecake Factory

$43.39

-0.79 (-1.79%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
Wedbush restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

BJRI

BJ's Restaurants

$43.61

0.81 (1.89%)

CAKE

Cheesecake Factory

$43.39

-0.79 (-1.79%)

CMG

Chipotle

$724.14

-3.035 (-0.42%)

DIN

Dine Brands

$95.49

0.235 (0.25%)

DRI

Darden

$122.14

0.92 (0.76%)

JACK

Jack in the Box

$82.83

-2.33 (-2.74%)

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

TXRH

Texas Roadhouse

$52.25

-0.1 (-0.19%)

WEN

Wendy's

$19.15

-0.22 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
Senate Agriculture, Nutrition & Forestry Committee to hold a hearing »

The Committee holds a…

MOR

MorphoSys

$26.23

1.16 (4.63%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
MorphoSys to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 07

    Aug

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Conference/Events
Goldman Sachs to hold a conference »

15th Annual European…

CBMG

Cellular Biomedicine

$15.01

(0.00%)

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Initiation
Cellular Biomedicine initiated  »

Cantor Fitzgerald bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$169.36

-1.48 (-0.87%)

, DGX

Quest Diagnostics

$100.87

-0.43 (-0.42%)

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Recommendations
LabCorp, Quest Diagnostics analyst commentary  »

Deutsche says…

LH

LabCorp

$169.36

-1.48 (-0.87%)

DGX

Quest Diagnostics

$100.87

-0.43 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.